Results from clinical studies strongly support the beneficial effects of glucose control, weight loss and lipid-lowering on coagulation dysfunctions, and glucose-lowering drugs, especially GLP-1 RAs and SGLT-2i’s, tend to ameliorate diabetes related hypercoagulation (Table 1). This evidence concerns the gene GLP1R and diabetes mellitus.